Heron Therapeutics reports plans to price public sale of common shares

Joint bookrunners Jefferies and Leerink Partners assist with offering

By Devika Patel

Knoxville, Tenn., June 24 – Heron Therapeutics Inc. will conduct a public offering of common stock with a 30-day greenshoe, according to a prospectus supplement filed Tuesday with the Securities and Exchange Commission.

Jefferies LLC and Leerink Partners LLC are the joint bookrunning managers.

Proceeds will be used for general corporate purposes.

The pharmaceutical company is based in Redwood City, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.